Emily Kay

894 total citations
14 papers, 239 citations indexed

About

Emily Kay is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Emily Kay has authored 14 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Emily Kay's work include Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Emily Kay is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Emily Kay collaborates with scholars based in United Kingdom, United States and Germany. Emily Kay's co-authors include Sara Zanivan, Grigorios Koulouras, Alessandro Rufini, Florian Hollfelder, Stéphane Emond, Nobuhiko Tokuriki, Sean R. A. Devenish, Andrew P. Porter, Simon J. Furney and Patricia Müller and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Emily Kay

13 papers receiving 238 citations

Peers

Emily Kay
Emily Kay
Citations per year, relative to Emily Kay Emily Kay (= 1×) peers David Sebinger

Countries citing papers authored by Emily Kay

Since Specialization
Citations

This map shows the geographic impact of Emily Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Kay more than expected).

Fields of papers citing papers by Emily Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Kay. The network helps show where Emily Kay may publish in the future.

Co-authorship network of co-authors of Emily Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Kay. A scholar is included among the top collaborators of Emily Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Kay. Emily Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kugeratski, Fernanda G., Emily Kay, & Sara Zanivan. (2025). Cancer-associated fibroblasts as mediators of tissue microenvironment remodeling in cancer. Current Opinion in Cell Biology. 96. 102567–102567.
2.
Kay, Emily & Sara Zanivan. (2025). The tumor microenvironment is an ecosystem sustained by metabolic interactions. Cell Reports. 44(3). 115432–115432. 15 indexed citations
3.
Santi, Alice, Emily Kay, Lisa J. Neilson, et al.. (2024). Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function. Science Signaling. 17(827). eade0580–eade0580. 14 indexed citations
4.
Kay, Emily, Sara Zanivan, & Alessandro Rufini. (2023). Proline metabolism shapes the tumor microenvironment: from collagen deposition to immune evasion. Current Opinion in Biotechnology. 84. 103011–103011. 26 indexed citations
5.
Neilson, Lisa J., Douglas Cartwright, Maija Risteli, et al.. (2023). Omentum-derived matrix enables the study of metastatic ovarian cancer and stromal cell functions in a physiologically relevant environment. SHILAP Revista de lepidopterología. 19-20. 100136–100136. 2 indexed citations
6.
Budden, Timothy, Caroline Gaudy‐Marqueste, Andrew P. Porter, et al.. (2021). Ultraviolet light-induced collagen degradation inhibits melanoma invasion. Nature Communications. 12(1). 2742–2742. 53 indexed citations
7.
Comitani, Federico, Rodrigo P. Feliciano, Leonie Johanna Jahn, et al.. (2021). Extraction and high-throughput sequencing of oak heartwood DNA: Assessing the feasibility of genome-wide DNA methylation profiling. PLoS ONE. 16(11). e0254971–e0254971. 2 indexed citations
8.
Kay, Emily, Grigorios Koulouras, & Sara Zanivan. (2021). Regulation of Extracellular Matrix Production in Activated Fibroblasts: Roles of Amino Acid Metabolism in Collagen Synthesis. Frontiers in Oncology. 11. 719922–719922. 56 indexed citations
9.
Kay, Emily & Sara Zanivan. (2021). Metabolic pathways fuelling protumourigenic cancer-associated fibroblast functions. Current Opinion in Systems Biology. 28. 100377–100377. 7 indexed citations
10.
Emond, Stéphane, et al.. (2020). Accessing unexplored regions of sequence space in directed enzyme evolution via insertion/deletion mutagenesis. Nature Communications. 11(1). 3469–3469. 46 indexed citations
11.
Kay, Emily, Lisa J. Neilson, Juan R. Hernández‐Fernaud, et al.. (2020). Abstract B76: Pyruvate dehydrogenase: A key to epigenetic regulation in CAFs. Clinical Cancer Research. 26(13_Supplement). B76–B76. 1 indexed citations
12.
Husain, Fatima T., et al.. (2019). Assessing mindfulness-based cognitive therapy intervention for tinnitus using behavioural measures and structural MRI: a pilot study. International Journal of Audiology. 58(12). 889–901. 14 indexed citations
13.
Kay, Emily, et al.. (2016). Radial Immunodiffusion Method for Evaluation of C1-Esterase Inhibitor Function. Journal of Allergy and Clinical Immunology. 137(2). AB253–AB253. 1 indexed citations
14.
Kay, Emily, et al.. (1997). Customer of one: the next market paradigm. 17(13). 38–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026